Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BMC Complementary Medicine and Therapies is Scopus-indexed (Q1, CiteScore 6.6), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 2662-7671Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Complementary and Alternative Medicine | 16 / 115 | 86th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q1, CiteScore 6.6.
BMC Complementary Medicine and Therapies is Q1 in Complementary and Alternative Medicine (rank 16 of 115), by CiteScore 2025.
BMC Complementary Medicine and Therapies is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.6, which places it in quartile Q1 at the 86th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.825, quartile Q1, with an H-index of 133.
The publisher lists an article processing charge of about US$2,195 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
BMC Complementary Medicine and Therapies is published by BioMed Central Ltd. Its ISSN is 2662-7671.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
BMC Complementary Medicine and Therapies has an h-index of 61 and a 2-year mean of 4.22 citations per paper (OpenAlex). Its Scopus CiteScore is 6.6, quartile Q1. On 2-year citations it ranks #9 of 109 Scopus journals in Complementary and Alternative Medicine.
BMC Complementary Medicine and Therapies published 495 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2026), authors are most often from China (26.4%), Iran (9.9%) and Türkiye (7.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 71 retracted papers are recorded (25.4 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.